Skip to main content
. Author manuscript; available in PMC: 2019 May 10.
Published in final edited form as: Eur J Med Chem. 2018 Apr 3;151:450–461. doi: 10.1016/j.ejmech.2018.04.006

Fig. 4.

Fig. 4

BRD4 inhibitors 28 and 35 effectively blocked TLR3 agonist-induced acute airway inflammation in vivo. Positive controls (+)-JQ1 and RVX-208 were also tested for comparison.